Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × eryaspase × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cyclophosphamide 257 Cisplatin 247 Radiotherapy 224 Paclitaxel 215 Docetaxel 196 Carboplatin 194 Fluorouracil 193 Doxorubicin 189 Dexamethasone 147 Gemcitabine 134 Vincristine 124 Capecitabine 115 Prednisone 112 Etoposide 111 Leucovorin 108 Methotrexate 103 Bevacizumab 103 Rituximab 97 Cytarabine 95 Filgrastim 84 Trastuzumab 81 Oxaliplatin 77 pembrolizumab 68 Pemetrexed 61 Drug Therapy 61 Tamoxifen 60 Epirubicin 57 Irinotecan 53 Chemotherapy, Adjuvant 52 Granulocyte Colony-Stimulating Factor 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03665441 2022-10-18

Trybeca-1

ERYtech Pharma

Phase 3 Completed

512 enrolled 19 charts

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡